CDC Casts Doubt on Covid Causing Kids’ Mysterious Liver Disease
(Bloomberg) --
U.S. health officials cast doubt on Covid-19 as a potential cause of severe hepatitis that's been seen in dozens of previously healthy children around the world, while adding weight to the possibility it's caused by a more common virus linked to stomach ailments.Â
The Centers for Disease Control and Prevention on Friday released its most detailed report yet on nine cases of pediatric hepatitis in Alabama that have captured national attention. All the patients tested negative for Covid-19 at the hospital and had no documented history of infection with SARS-CoV-2, the report said.
Covid has shown it can damage a variety of organs, including the liver, raising the possibility that it could be linked to the more than 160 worldwide cases seen so far of unexplained liver disease in children. U.K. experts said earlier this week that the condition might be connected to adenoviruses, a family of pathogens that more commonly cause cold and flu symptoms.
In their description of the Alabama cluster last week, health officials noted that several children had tested positive for adenovirus type 41, which usually causes pediatric acute gastroenteritis — sometimes called stomach flu — leading to nausea, vomiting, diarrhea and sometimes more severe symptoms. Friday's report confirmed that all five patients whose samples were sequenced showed signs of the same virus type, raising the specter of a possible causal link.
Adenovirus is known to cause hepatitis in immunocompromised children, but in light of the new findings, the CDC report notes, “it might be an underrecognized contributor to liver injury among healthy children.” Adenovirus should be considered among possible explanations for these cases, but the extent of the relationship remains under investigation, the report said.
The disorder has been seen mainly in children younger than 10 and has left a few needing liver transplants. Officials in Wisconsin said earlier this week that one of the cases under investigation resulted in a fatality. So far, no other U.S. cases linked to the disorder have resulted in death.Â
A separate report from the World Health Organization said it's unlikely that Covid vaccination could be the cause, as the majority of kids haven't been immunized. None of the cases have been traced to a family of viruses known to cause acute hepatitis, but more than 75% have tested positive for adenovirus.
Expanding Investigation
Health officials in eight states have confirmed or are investigating cases matching the CDC's initial description of those in Alabama. Most of the children also tested positive for adenovirus, state health officials say.
Public health officials in California and Colorado said in emailed statements that they are now investigating cases. Delaware, North Carolina and Illinois earlier confirmed cases. Health officials in New York state and Wisconsin also have said they're investigating reports that match the CDC's description.
The CDC has not yet responded to requests asking for additional information about how it plans to confirm the cases reported by health departments. However, the additional clinical details included in Friday's report contain some information health experts have said could help nail down which cases match those found in Alabama.
Hepatitis doesn't occur frequently in kids, but is not necessarily rare, said Saul Karpen, a pediatric liver expert at Children's Healthcare of Atlanta and board member of the American Association for the Study of Liver Diseases. Cases caused by known liver viruses are usually reported to local health departments and tracked by the CDC.Â
Karpen said that about 10% of his pediatric patients with liver transplants have disease that wasn't caused by one of the recognized liver viruses. What's remarkable about these liver patients with unexplained disease, he said, is that so many of them have adenovirus 41, and that the cases are so severe.
“The balance between alarm and concern here is real,” Karpen said. While the cases are definitely cause for heightened awareness, he does not think parents should yet be worried.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.